Skip to main content

Table 3 Demographic Data

From: The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery

 

MB Group

n = 311

Non-MB Group

n = 202

p-value

Age [years]

65.7 ± 12.0

65.8 ± 11.4

n.s.

Male

243 [78]

163 [81]

n.s.

BMI [kg/m2]

31.7 ± 57.8

27.7 ± 6.5

n.s.

ASA

1–2

5 [2]

8 [4]

0.001

3

136 [46]

122 [60]

 

4

138 [47]

67 [33]

 

5

12 [4]

1 [1]

 

Nicotine Abuse

94 [32]

71 [35]

n.s.

Coronary Heart Disease

191 [65]

144 [71]

n.s.

With Stent

22 [7]

11 [5]

n.s.

Angina Pectoris

67 [23]

79 [39]

0.001

Previous Myocardial Infarction

81 [27]

35 [17]

0.009

NYHA

1

1 [0.3]

0

0.014

2

15 [5]

7 [4]

 

3

162 [56]

143 [71]

 

4

106 [36]

47 [23]

 

Left Ventricular Ejection Fraction [%]

47.5 ± 18.8

45.8 ± 17.

n.s.

Pacemaker

23 [8]

13 [6]

n.s.

Hypertension

203 [69]

147 [75]

n.s.

Peripheral Arterial Disease

47 [16]

36 [18]

n.s.

With Stent

25 [8]

17 [8]

n.s.

Pulmonary Hypertension

30 [10]

16 [8]

n.s.

Renal Failure

GFR > 89 mL/min

35 [11]

42 [21]

0.004

GFR 60–89

64 [21]

58 [29]

 

GFR 30–59

59 [19]

38 [19]

 

GFR < 30

29 [9]

9 [5]

 

Dialysis

1 [0.3]

0

 

Cerebrovascular Events

20 [7]

6 [3]

n.s.

Allergy

54 [18]

39 [19]

n.s.

  1. BM Body mass index, ASA American Society of Anesthesiologists, NYHA New York Heart Association, GFR Glomerular filtration rate; All data are presented as number [%] or mean +/− SD. n.s.: not significant